Armando Rossello Selected Research

Armando Rossello Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 11/2006
6	Osteoarthritis 01/2021 - 08/2009
5	Neoplasm Metastasis (Metastasis) 03/2017 - 01/2010
4	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 03/2016
4	Inflammation (Inflammations) 01/2021 - 03/2014
4	Ovarian Epithelial Carcinoma 10/2013 - 12/2007
3	Lymphoma (Lymphomas) 01/2022 - 05/2016
3	Pathologic Processes 12/2020 - 10/2013
3	Rheumatoid Arthritis 01/2013 - 10/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2016
2	Atherosclerosis 12/2021 - 10/2009
2	Glaucoma 12/2020 - 11/2014
2	Fibrosarcoma 01/2019 - 05/2004
2	Glioma (Gliomas) 03/2017 - 07/2011
2	Cardiomyopathies (Cardiomyopathy) 01/2016 - 01/2013
2	Arthritis (Polyarthritis) 03/2014 - 09/2012
2	Carcinogenesis 10/2013 - 03/2007
2	Multiple Sclerosis 01/2013 - 04/2011
1	Central Nervous System Diseases (CNS Diseases) 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021
1	Uveal melanoma 12/2021
1	Epilepsy (Aura) 12/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Diabetes Complications 01/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2016
1	Burns 11/2016
1	Hypertrophy 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2016
1	Amyloidosis 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Amyloid Neuropathies (Amyloid Neuropathy) 01/2016

Drug/Important Bio-Agent (IBA)

14	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 05/2004
12	Metalloproteases (Metalloproteinases)IBA 11/2021 - 12/2007
12	EnzymesIBA 01/2019 - 11/2006
7	Pharmaceutical PreparationsIBA 01/2022 - 05/2004
5	LigandsIBA 01/2019 - 01/2016
5	Biological ProductsIBA 03/2017 - 08/2009
5	Matrix Metalloproteinase InhibitorsIBA 05/2014 - 07/2011
5	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2013 - 12/2007
4	DisintegrinsIBA 01/2019 - 11/2014
4	Proteins (Proteins, Gene)FDA Link 03/2017 - 07/2011
4	Protein Isoforms (Isoforms)IBA 11/2014 - 12/2008
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2020 - 03/2007
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 10/2013
3	ZincIBA 01/2019 - 09/2012
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2018
2	CollagenIBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
2	Brentuximab VedotinIBA 01/2022 - 01/2018
2	Peptide Hydrolases (Proteases)FDA Link 12/2021 - 04/2013
2	aggrecanaseIBA 01/2021 - 04/2013
2	Prealbumin (Transthyretin)IBA 01/2016 - 01/2016
2	Matrix Metalloproteinase 13IBA 03/2014 - 08/2009
2	GelatinasesIBA 07/2011 - 03/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	OximesIBA 12/2021
1	Ether (Diethyl Ether)IBA 12/2021
1	Histone Deacetylase InhibitorsIBA 12/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Carbon DioxideIBA 12/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 12/2020
1	LipopolysaccharidesIBA 01/2020
1	progelatinaseIBA 01/2019
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2019
1	Natural Cytotoxicity Triggering Receptor 3IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	micaIBA 01/2018
1	iratumumabIBA 01/2018
1	CytokinesIBA 01/2018
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	NADP (NADPH)IBA 01/2017
1	polyolIBA 01/2017
1	Messenger RNA (mRNA)IBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 11/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2016
1	AlkaliesIBA 11/2016
1	Angiotensin IIIBA 10/2016
1	ErbB Receptors (EGF Receptor)IBA 10/2016
1	FlavonoidsIBA 09/2016
1	Protein Kinases (Protein Kinase)IBA 09/2016
1	Adenosine Monophosphate (AMP)IBA 09/2016
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2016
1	CoumarinsIBA 11/2014
1	dorzolamide (Trusopt)FDA LinkGeneric 11/2014
1	Proto-Oncogene Proteins c-metIBA 11/2014
1	AlbuminsIBA 05/2014
1	Matrix Metalloproteinase 12IBA 03/2014
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 03/2014
1	ZymosanIBA 03/2014

Therapy/Procedure

11	Therapeutics 03/2017 - 11/2006
2	Immunotherapy 01/2022 - 01/2018